Skip to main content

Find Clinical Trials

Home
Conditions
Liver Diseases

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,421 public trials 1,317 recruiting studies

Refine in advanced search Browse all conditions

Liver Diseases trial results

Completed

Anti-Fibrotic Effects of Losartan In Nash Evaluation Study

NCT01051219

Conditions: Digestive System Diseases, Fatty Liver, Fibrosis, +6 more
Locations: Plymouth Hospitals NHS Trust Plymouth, Devon, United Kingdom

Queen Elizabeth Hospital Birmingham, United Kingdom

Cambridge University NHS Foundation Trust Cambridge, United Kingdom

Royal Derby Hospital Derby, United Kingdom

View Trial Details

Completed

Impact of Patient Support by the Medical Staff on Adherence to Therapy With PegIntron Plus Rebetol (Study P04413)

NCT00704964

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Not specified

View Trial Details

Completed

Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04281)(COMPLETED)

NCT00704522

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations: Not specified

View Trial Details

Completed

Quantification of Side Effects During Hepatitis C Therapy

NCT02545400

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Department of Internal Medicine, Medical University of Graz Graz, Austria

View Trial Details

Completed

Treatment of Patients With Chronic Hepatitis C With PegIntron as Monotherapy or in Combination With Ribavirin (Study P04437)(COMPLETED)

NCT00705666

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations: Not specified

View Trial Details

Completed

Pharmacoeconomic Study Assessing the Cost of Chronic Hepatitis C Treatment With Peginterferon Alfa-2b (PegIntron) and Ribavirin (Rebetol) in the Czech Republic (Study P04588)(COMPLETED)

NCT00723632

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Treatment of Chronic Hepatitis C With Pegylated Interferon and Ribavirin in Participants With/Without Substitution Therapy (P05255)

NCT00725751

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Sleeve Gastrectomy in Adolescents With Complicated Morbid Obesity and NAFLD

NCT02564679

Conditions: Body Weight, Digestive System Diseases, Fatty Liver, +12 more
Locations: Not specified

View Trial Details

Completed

Safety of Two Doses of Avaxim® 80U Pediatric (Inactivated Hepatitis A Vaccine) in Toddlers, Children and Adolescents

NCT02011763

Conditions: Digestive System Diseases, Enterovirus Infections, Hepatitis, +8 more
Locations: Beijing, China

View Trial Details

Completed

Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV

NCT02032901

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Scripps Clinic La Jolla, California, United States

Peter J Ruane MD Inc Los Angeles, California, United States

National Research Institute Los Angeles, California, United States

Anthony M. Mills MD Inc Los Angeles, California, United States

View all 31 locations

View Trial Details